These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22087503

  • 21. Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.
    Kølbæk P, Dines D, Holm T, Blicher AB, Sørensen RD, O'Leary KM, Feller SG, Buus CW, Nielsen CM, Opler M, Mors O, Correll CU, Østergaard SD.
    J Psychopharmacol; 2021 Sep; 35(9):1081-1090. PubMed ID: 33779360
    [Abstract] [Full Text] [Related]

  • 22. Validity and Reliability of the Arabic Version of the Positive and Negative Syndrome Scale.
    Yehya A, Ghuloum S, Mahfoud Z, Opler M, Khan A, Hammoudeh S, Abdulhakam A, Al-Mujalli A, Hani Y, Elsherbiny R, Al-Amin H.
    Psychopathology; 2016 Sep; 49(3):181-7. PubMed ID: 27475457
    [Abstract] [Full Text] [Related]

  • 23. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.
    J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Validation of Turkish version of brief negative symptom scale.
    Polat Nazlı I, Ergül C, Aydemir Ö, Chandhoke S, Üçok A, Gönül AS.
    Int J Psychiatry Clin Pract; 2016 Nov; 20(4):265-71. PubMed ID: 27409157
    [Abstract] [Full Text] [Related]

  • 29. A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups.
    Khan A, Yavorsky C, Liechti S, Opler M, Rothman B, DiClemente G, Lucic L, Jovic S, Inada T, Yang L.
    BMC Psychol; 2013 Nov; 1(1):5. PubMed ID: 25566357
    [Abstract] [Full Text] [Related]

  • 30. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF, de Resende CB, Abreu MN, Rocha FL, Teixeira AL, Keefe RS, Salgado JV.
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Equipercentile linking of the BPRS and the PANSS.
    Leucht S, Rothe P, Davis JM, Engel RR.
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia.
    Krekels E, Novakovic AM, Vermeulen AM, Friberg LE, Karlsson MO.
    CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):543-551. PubMed ID: 28571119
    [Abstract] [Full Text] [Related]

  • 35. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS).
    Khan A, Yavorsky WC, Liechti S, DiClemente G, Rothman B, Opler M, DeFries A, Jovic S.
    J Clin Psychopharmacol; 2013 Feb; 33(1):109-17. PubMed ID: 23277234
    [Abstract] [Full Text] [Related]

  • 36. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP, Brown E, Baker RW, Schuh LM, Shao L, Tohen M, Ahmed S, Stauffer VL.
    Schizophr Res; 2004 Jun 01; 68(2-3):331-7. PubMed ID: 15099614
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.
    Pinna F, Fiorillo A, Tusconi M, Guiso B, Carpiniello B.
    Int J Ment Health Syst; 2015 Jun 01; 9():37. PubMed ID: 26526168
    [Abstract] [Full Text] [Related]

  • 39. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.
    Glick HA, Li P, Harvey PD.
    Schizophr Res; 2015 Aug 01; 166(1-3):110-4. PubMed ID: 26044113
    [Abstract] [Full Text] [Related]

  • 40. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY, Kim SH, Cho SJ, Chung YC, Jung IK, Kim CY, Kim DH, Lee DG, Lee YH, Lim WJ, Na YS, Shin SE, Woo JM, Yoon JS, Yoon BH, Ahn YM, Kim YS.
    Int Clin Psychopharmacol; 2014 Sep 01; 29(5):279-87. PubMed ID: 24583566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.